4//SEC Filing
LAUER REGAN J 4
Accession 0001326110-23-000114
CIK 0001326110other
Filed
Sep 5, 8:00 PM ET
Accepted
Sep 6, 7:40 PM ET
Size
7.3 KB
Accession
0001326110-23-000114
Insider Transaction Report
Form 4
LAUER REGAN J
Chief Accounting Officer
Transactions
- Exercise/Conversion
Common Stock
2023-09-01+32,872→ 53,902 total - Exercise/Conversion
Restricted Stock Units
2023-09-01−32,872→ 32,872 total→ Common Stock (32,872 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of ImmunityBio, Inc. common stock.
- [F2]Subject to the reporting person's continuing to be a Service Provider (as defined in the Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, fifty percent (50%) of the RSUs subject to the award vested on September 1, 2023 and the remaining fifty percent (50%) of the RSUs subject to the award shall vest on January 31, 2024.
Documents
Issuer
ImmunityBio, Inc.
CIK 0001326110
Entity typeother
Related Parties
1- filerCIK 0001200637
Filing Metadata
- Form type
- 4
- Filed
- Sep 5, 8:00 PM ET
- Accepted
- Sep 6, 7:40 PM ET
- Size
- 7.3 KB